Latest Information Update: 29 Nov 2006
At a glance
- Originator Roche
- Mechanism of Action Serotonin 6 receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Cognition disorders
Most Recent Events
- 04 Nov 1999 Preclinical development for Cognition disorders in Switzerland (Unknown route)